Pharmallama, a leading pharmaceutical brand, is introduced, and dedicated to providing high-quality healthcare solutions. Pharmallama specializes in pre-sorted medicines that are conveniently packaged in sachets, ensuring easy administration and accurate dosing for patients of all ages.
With Pharmallama, one can trust that their health and well-being are in capable hands.
Pharmaceuticals Business in India(Case Study)
The hassle of dealing with multiple pill bottles and complicated medication schedules can be bid farewell. Pharmallama’s innovative packaging solution simplifies the healthcare routine, making it easier than ever to stay on track with treatment.
Whether managing chronic conditions, organizing medications for a loved one, or seeking an efficient solution for travel, Pharmallama has it covered. The extensive range of products encompasses various therapeutic areas, ensuring the receipt of the right medication in the right dose at the right time.
Stringent quality control measures guarantee the safety and efficacy of every sachet, delivering the confidence needed to manage health effectively. Pharmallama empowers individuals to take control of their well-being with simplicity and precision.
Healthcare providers can be consulted or the nearest pharmacy visited to inquire about the extensive product range. Let Pharmallama revolutionize the way medication is taken, making it easier, safer, and more convenient than ever before.
When it comes to health, Pharmallama is a trusted partner, committed to simplifying medication regimens and enhancing overall well-being. Choosing Pharmallama means experiencing the difference today!
Entrepreneur Name- Arjun Raghunandan, Achintya Dayal and Dipesh Rajpal
About the Entrepreneur- The company Pharmallama has been founded by Arjun Raghunandan, Achintya Dayal, and Dipesh Rajpal.
LinkedIn Profiles
| Arjun Raghunandan, | https://www.linkedin.com/in/achintyadayal/ |
| Achintya Dayal | https://www.linkedin.com/in/arjun-raghunandan/ |
| Brand Name– | Pharmallama |
| Brand Website- | https://pharmallama.com/ |
| Business Category– | Pharmaceuticals |
Innovation;- Yes, Pharmallama aims to offer a complete pharmacy service and a comprehensive drug management platform to eliminate the need for elderly and sick individuals to queue up, arrange their pills, or face challenges in locating the correct medication based on their prescription.
Pharmallama has devised a distinctive solution that simplifies the process of drug management, making it easy and convenient to purchase and consume medication.
| Company Valuation– | ₹50 Crores |
| Equity Asked– | ₹2 cr for 5% Equity |
| Deal Closed– | Yes. |
| Final Shark Tank Deal– | ₹2 cr for 5% Equity |
| Target City/Country- | India. |
| Total Addressable Market- | $50 Billion |
| Product/Services– | Pre-sorted Medicines in Sachet |
About the Product- Many of us have disorganized medicine cabinets and struggle to decipher prescriptions when taking medication.
For about 40% of elderly individuals, accurately taking their medicine at the correct time is critical to their health.
Pharmallama offers a unique solution to this issue by utilizing its proprietary technology, which allows machines to interpret prescriptions and divide medications into small packets.
Each packet includes the medication name, date, dose, and time.
The company was launched in April 2022 and has already served over 5,000 customers. Their goal is to replace the chaotic medicine box with their system.
To get started, customers simply take a clear photo of their prescription and upload it to the website, after which a registered pharmacist verifies its authenticity and confirms the price with the patient.
Once the order is processed, the medications are fed into the machines, undergo quality checks, and are finally packed into individual packets.
Conclusion–
Arjun Raghunandan, Achintya Dayal, and Dipesh Rajpal initially requested 1 crore rupees for a 1.5% stake in the company.
Shark Anupam made an offer of 1 crore rupees for a 2.2% stake. Later, all five sharks collectively offered 2 crores for a 5% stake in the company.
However, the owners made a counteroffer of 2 crores for a 4% stake.After negotiations, the final deal was ultimately sealed with all five sharks – Peyush, Aman, Namita, Amit, and Aman – for 2 crores at a 5% equity share in the company.
